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Objectives We sought to prospectively evaluate risk of stroke and impact of transcatheter patent foramen ovale (PFO) clo-
sure in patients with permanent right-to left shunt compared with those with Valsalva maneuver-induced right-to-
left shunt.
Background Pathophysiology and properly management of PFO still remain far from being fully clarified: in particular, the
contribution of permanent right-to-left shunt remains unknown.
Methods Between March 2006 and October 2010, we enrolled 180 (mean age 44  10.9 years, 98 women) of 320 con-
secutive patients referred to our center for transcatheter PFO closure, who had spontaneous permanent right-to-
left shunt on transcranial Doppler and transthoracic/transesophageal echocardiography. All patients fulfilled the
standard current indications for transcatheter closure and underwent preoperative transesophageal echocardiog-
raphy and brain magnetic resonance imaging, with subsequent intracardiac echocardiographic-guided transcath-
eter PFO closure. We compared the clinical echocardiographic characteristics of these patients (Permanent
Group) with the rest of 140 patients with right-to-left shunt only during Valsalva maneuver (Valsalva Group).
Results Compared with the Valsalva Group patients, patients of the Permanent Group had increased frequency of multi-
ple ischemic brain lesions on magnetic resonance imaging, previous recurrent stroke, previous peripheral arter-
ies embolism, migraine with aura, and—more frequently—atrial septal aneurysm and prominent Eustachian
valve. The presence of permanent shunt confers the highest risk of recurrent stroke (odds ratio: 5.9, 95% confi-
dence interval: 2.0 to 12, p  0.001). No differences were recorded between the 2 groups with regard to recur-
rence of ischemic events after the closure procedure.
Conclusions Despite its small-sample nature, our study suggests that patients with permanent right-to-left shunt have poten-
tially a higher risk of paradoxical embolism compared with those without. (J Am Coll Cardiol 2011;58:
2257–61) © 2011 by the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.06.064Pathophysiology and proper management of patent foramen
ovale (PFO) still remain far from being fully clarified: in
particular, the anatomical and functional characteristics of
PFO conferring an actual risk of recurrent stroke are still
poorly understood. Our group (1,2) and other authors
recently suggested large PFO, atrial septal aneurysm (ASA),
long tunnelized PFO, and prominent Eustachian valve
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accepted June 16, 2011.(EV) as concurrent risk factors for recurrent stroke. The
contribution of spontaneous right-to-left shunt still remains
debated. Recently, different studies (3,4) about shunt grade
resulted in contrasting data in favor of or against an
increasing risk conferred by a large or permanent shunt. We
sought to prospectively evaluate risk of stroke and impact of
transcatheter PFO closure in patients with permanent
right-to left shunt, compared with those with Valsalva
maneuver-induced right-to-left shunt.
Methods
Between March 2006 and October 2010, we prospectively
enrolled 320 consecutive patients referred to our center for
transcatheter PFO closure. All patients fulfilled the stan-
dard current indications for transcatheter closure (5) and
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nial Doppler (TCD), TEE, and
brain magnetic resonance imaging
(MRI), with subsequent intracar-
diac echocardiographic-guided
transcatheter PFO closure. We
compared the clinical and echocar-
diographic characteristics of pa-
tients with permanent (Permanent
group) versus Valsalva only-
induced right-to-left shunt (Val-
salva group) and the potential
impact of transcatheter closure.
In particular, the 2 groups were
matched by combined cardiolog-
ical and neurological team mem-
bers for previous medical history, brain MRI, number of
clinically confirmed stroke episodes, and migraine presence
and severity. Written informed consent was obtained from
all patients enrolled in the study.
Echographic protocols and definitions. The TEE was
conducted with a GE Vivid 7 (General Electric Corpora-
tion, Norfolk, Virginia) with contrast injection and Valsalva
maneuver under local anesthesia: right-to-left shunts were
defined as permanent, small, medium, and large following
Homma et al. (6), whereas ASA and prominent EV were
defined following standard nomenclature (7). The PFO
diameter was calculated with electronic caliper, measuring
the maximum opening of the PFO in the end-diastolic
frames.
The TCD was performed with intravenous bubble
study by a seasoned neurologist experienced in this
examination, according to current standard (8) with a
TCD monitoring device (DWL MultidopX, ScanMed
Medical, Gloucestershire, United Kingdom). Both mid-
dle cerebral arteries were simultaneously monitored
through the temporal window by the use of 2-MHz
probes. The contrast was obtained by mixing 100 ml of
saline solution with 2 to 3 ml of Emagel and loading a 10
cc syringe with this mixture. The solution, agitated
between 2 10-ml syringes and connected by a 3-way
stopcock, was immediately injected with a 20-gauge/
32-mm catheter placed in the antecubital vein to obtain
a bolus of air microbubbles. This procedure was per-
formed 3 times during normal breathing and the same
number of times during a Valsalva maneuver. The bolus
of microbubbles was injected in 1 to 2 s when this 7-s
period ended. We quantified the importance of right-to-
left shunt by counting the number of signals in 1 middle
cerebral artery within 7 s of the injection, as previously
reported (8).
For intracardiac echocardiography (ICE), all the right
atrial and interatrial septal characteristics other than PFO
and mild ASA (1 right or 2 left by Olivares classification)
(9) were recorded, including: prominent EV (defined as
Abbreviations
and Acronyms
ASA  atrial septal
aneurysm
EV  Eustachian valve
ICE  intracardiac
echocardiography
MRI  magnetic resonance
imaging
PFO  patent foramen
ovale
TCD  transcranial Doppler
TEE  transesophageal
echocardiographyvalve thickness 1 mm with at least 10-mm protrusionwithin the right atrium, as measured from the border of the
inferior vena cava) (7), moderate-to-severe ASA (3 right-
to-left, 3 left-to-right up to 5 right-to-left by Olivares
classification) (9), and PFO diameter (as a mean of 2
measurements, obtained by measuring with the electronic
caliper the maximum opening of the PFO in the end-
diastolic frames in both the aortic valve and 4-chamber view
planes). Patients who fulfilled the criteria for PFO closure
underwent ICE evaluation with the mechanical 9-F,
9-MHz UltraICE catheter (EP Technologies, Boston Sci-
entific Corporation, San Jose, California). The ICE study
was conducted as previously described (10), by performing a
manual pull-back from the superior vena cava to the inferior
vena cava through 5 sectional planes; ICE monitoring of the
implantation procedure was conducted in the 4-chamber
plane (11).
Migraine evaluation. Migraine with and without aura
were diagnosed according to the International Headache
Society criteria and Migraine Disability Assessment Score
(12) as a part of clinical assessment of PFO.
Closure protocol. Combined antibiotic therapy (genta-
micin 80 mg  ampicillin 1 g or vancomycin 1 g if allergy
has been recorded on anamnesis) was administered intra-
venously 1 h before the procedure. The operators selected
the Amplatzer Occluder family (PFO Occluder, Cribri-
form Occluder, AGA Medical Corporation, Golden
Valley, Minnesota) or the Premiere Closure System (St.
Jude Medical, Inc., St. Paul, Minnesota), on the basis
of ICE study and the presence/absence of moderate-
to-large ASA and long tunnel-like PFO (tunnel length
12 mm).
Follow-up protocol. Follow-up was conducted with TEE
at 1 month (with repeat study at 6 months if at least a small
shunt was detected); transthoracic echocardiography at 1, 6,
and 12 months; TCD at 1 month; electrocardiographic
Holter monitoring at 1 month; and combined cardiological
Comparison of Demographic Clinicaland Functional Parameters Between PatientsWith Permanent and V lsalva-Induced Shunt
Table 1
Comp rison of Demographic Clinical
and Functional Parameters Between Patients
With Permanent and Valsalva-Induced Shunt
Permanent
(n  180)
Valsalva
(n  140) p Value
Age (yrs) 44 10.9 48 7.8 NS
Female 128/180 (71.1%) 101/140 (72.1%) NS
Smoking 89/180 (49.4%) 64/140 (45.7%) NS
High blood pressure 29/180 (16.1%) 19/140 (13.5%) NS
Hypercholesterolemia 32/180 (17.7%) 27/140 (19.2%) NS
Oral contraception 54/180 (30%) 39/140 (27.8%) NS
Deficiency of anti-thrombin
III, C, S
6/180 (3.3%) 3/140 (2.1%) NS
Factor V Leiden 5/180 (2.7%) 3/140 (2.1%) NS
Mutation MTHFR (homozygote) 32/180 (17.7%) 27/140 (19.2%) NS
Hyperhomocysteinemia 21/180 (11.6%) 15/140 (10.7%) NS
Antiphospholipid or
anticardiolipin antibodies
3/180 (1.6%) 2/140 (1.4%) NSValues are mean  SD or n/N (%).
MTHFR  5,10-methylen-tetraydrofolate reductase.
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was assessed by contrast TEE and TCD (13). Brain MRI
was repeated at 12-month follow-up.
Statistical analysis. Chi-square, analysis of variance, and
Student t tests were used to compare frequencies and contin-
uous variables between the groups. Stepwise logistic regression
analysis was used to determine independent determinants of
preoperative recurrent strokes. The analyzed variables were age
45 years, sex, moderate-to-severe ASA, shower pattern on
TCD, curtain pattern on TCD, permanent shunt on TEE or
TCD, medium-to-large shunt on TEE, and prominent EV.
Statistical analysis was performed with a statistical software
Comparison of Functional andAnatom cal Parameters Between PatientsWith Permanent and With Valsalva-Induced Shunt
Table 2
Comparison of Functional and
Anatomical Parameters Between Patients
With Permanent and With Valsalva-Induced Shunt
Permanent Valsalva p Value
TEE PFO mean diameter (mm) 9.1 3.2 6.3 2.5 0.001
ICE PFO mean diameter (mm) 11.1 2.9 8.9 2.2 0.001
Shower shunt pattern TCD 9/180 (16.1%) 94/140 (67.1%) 0.01
Curtain shunt pattern TCD 151/180 (83.8%) 46/140 (32.8%) 0.01
Medium shunt TEE 32/180 (17.8%) 53/140 (37.8%) 0.01
Large shunt TEE 148/180 (82.2%) 87/140 (62.1%) 0.01
ASA 1 to 2 RL or LR 77/180 (42.7%) 68/140 (48.6%) NS
ASA 3 to 5 RL or LR 81/180 (45%) 34/140 (24.3%) 0.01
EV/Chiari network 131/180 (72.7%) 45/140 (32.1%) 0.01
Values are mean  SD or n/N (%).
ASA  atrial septal aneurysm; EV  Eustachian valve; LR  left-to-right; PFO  patent foramen
vale; RL  right-to-left; TCD  transcranial Doppler; TEE  transesophageal echocardiography.
Figure 1 Clinical Profile Comparison Between Permanent and V
Histogram representation of the comparison of clinical history between patients w
(Bottom) The nominal number of patients for each group. MRI  magnetic resonapackage (SAS for Windows, version 8.2, SAS Institute, Cary,
North Carolina). A probability value of 0.05 was considered
to be statistically significant.
Results
On both TCD and TEE, 180 patients (mean age 44 10.9
years, 128 women) had permanent shunt (Permanent Shunt
group) (Table 1), whereas 140 patients had only Valsalva-
induced shunt (Valsalva Shunt group) (Table 1). Compared
with the Valsalva Group, patients of Permanent Group
more frequently had ASA and prominent EV (Table 2) and
increased frequency of multiple ischemic brain lesions on
MRI, previous recurrent stroke, previous peripheral arteries
embolism, and migraine with aura (Fig. 1).
No differences were recorded between the 2 groups with
regard to procedure success, ischemic events recurrence, or
new ischemic lesions appearance on brain MRI after the
closure procedure; moreover, in the Permanent group resid-
ual shunts were more frequent at follow-up (Table 3).
Multiple stepwise logistic regression analysis of enrolled
baseline and clinical variables demonstrated that permanent
shunt confers the highest risk of recurrent stroke (odds ratio:
5.9, 95% confidence interval: 2.0 to 12.0, p  0.001),
whereas ASA (odds ratio: 3.9, 95% confidence interval: 0.5
to 7.0, p  0.001) was the only other strong independent
predictor.
lva Shunt Patients
manent shunt and Valsalva-induced shunt.
aging; MwA  migraine with aura; MwoA  migraine without aura.alsa
ith per
nce im
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Our study suggests that patients with permanent right-to-
left shunt represent a subgroup at potentially higher risk of
paradoxical embolism and that permanent right-to-left
shunt can be considered an independent risk factor for
recurrent paradoxical embolism. In addition, our data dem-
onstrate that permanent right-to-left shunt—being linked
with ASA, in particular moderate or large—might be
related also with a higher proportion of residual shunts after
closure, compared with patients with Valsalva-induced
right-to-left shunt.
Past and recent published reports have shown the con-
tribution of shunt degree to be both enhanced and limited.
A higher embolic risk has been reported with medium-to-
large shunts, particularly in association with migraine or
coagulation abnormalities (14). Furthermore, TCD studies
have correlated the shower or curtain shunt pattern with
significant PFO on TEE (15) as well as history of paradox-
ical embolism. In further concordance with published re-
ports, the higher frequency of large ASA and prominent EV
in our study is closely linked to the presence and severity of
spontaneous right-to-left shunt (16). More recently, the
CODICIA (Right-to-Left Shunt in Cryptogenic Stroke)
study (17) concluded that neither massive nor massive shunt
associated with ASA was an independent risk factor for
recurrent stroke. Unfortunately no mention was made about
faith of patients with presence of permanent shunt in this
study or in the study by Goel et al. (18), which clearly
demonstrated that in symptomatic patients the PFO is
associated with larger shunt and longer tunnel and more
frequently with ASA.
Permanent shunt usually corresponds to large shunt
induced by Valsalva maneuver, but the correlation is not
always linear in clinical practice: sometimes permanent
shunt might correspond only to moderate (shower pattern)
shunt after Valsalva: this might explain the mixed results
observed in the aforementioned studies.
We believe, by contrast, that permanent shunt is the most
nonphysiological condition among the different flow pattern
of right-to-left shunt: this hypothesis seems to be supported
also by our previous studies, in which both ASA and
permanent right-to-left shunt seemed correlated with a
Comparison of Procedural andF llow-Up Results Between Patients WithPermanent and With Valsalva-Induced Shunt
Table 3
Comparison of Proc dural and
Follow-Up Results Between Patients With
Permanent and With Valsalva-Induced Shunt
Permanent Valsalva p Value
Immediate success 180/180 (100%) 140/140 (100%) NS
Recurrence of ischemic event 0/180 (0%) 0/140 (0%) NS
New MRI lesions 0/180 (0%) 0/140 (0%) NS
Complete occlusion 164/180 (91.1%) 133/140 (95%) NS
Residual shunt small 14/180 (7.7%)* 3/180 (2.1%)† 0.025
Values are mean  SD or n/N (%). *13 patients had a small shunt, and 1 patient had a moderate
shunt. †2 patients had a small shunt, and 1 patient had a moderate shunt.
MRI  magnetic resonance imaging.certain degree of left atrial dysfunction (19). The improve-ment of left atrial dysfunction when the permanent shunt
was abolished after device closure in patients with a perma-
nent shunt and ASA supports the role of permanent shunt
in the pathophysiology of paradoxical embolism, even if a
portion of ASA remains uncovered. The current study
further confirmed this hypothesis and also the link between
prominent EV and permanent shunt, a correlation already
suggested by Schuchlens et al. (20).
Conclusions
To our knowledge, our study is the first systematic analysis
evaluating the clinical and procedural implications of per-
manent right-to-left shunt. Further larger prospective stud-
ies probably should take into account that the presence and
severity of spontaneous right-to-left shunt might be closely
related to ASA and that prominent EV and large ASA
might be potential markers of a high-risk profile for
paradoxical embolism.
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